Jupiter Life Line Hospitals (JLHL) Q1 23/24 earnings summary

Executive summary

• Q1FY24 revenue grew 21.3% YoY to ₹243.2 crore; EBITDA rose 7.5% to ₹53.0 crore, while PAT of ₹54.0 crore included a ₹30.44 crore deferred-tax benefit.

• Occupancy improved to 57.2% from 52.1% YoY, and IPD and OPD volumes increased 17.8% and 18.4%, respectively.

Financial highlights

• Revenue from operations was ₹243.2 crore vs ₹200.6 crore YoY; gross profit was ₹138.9 crore vs ₹119.0 crore.

• EBITDA was ₹53.0 crore vs ₹49.3 crore YoY; EBIT was ₹47.3 crore vs ₹42.0 crore, and PBT was ₹33.8 crore vs ₹32.0 crore.

• PAT was ₹54.0 crore vs ₹30.4 crore YoY, including a ₹30.44 crore deferred-tax benefit; diluted EPS was ₹9.93 vs ₹5.99.

Outlook and guidance

• Dombivli greenfield hospital, planned for 500 beds and 600,000 sq. ft., was under construction after work began in April 2023; progress was described as on schedule.

• Long-term expansion plans target 2,500 total beds through new hospitals in western India over the coming years.

• Improved occupancy at Indore and Pune was identified as a growth driver for coming quarters; ARPOB remained above ₹55,000.